Future Market Insights (FMI) delivers key insights on the global pharmacovigilance market in its upcoming outlook titled “Pharmacovigilance Market: Global Industry Analysis and Opportunity Assessment, 2015 - 2020”. In terms of revenue, the global pharmacovigilance market is estimated to expand at a healthy CAGR of 14.2% through 2020. The global pharmacovigilance market was valued at US$ 2,759. ... Read more
Pharmacovigilance (PV) is a process refereeing to the detection, collection, prevention, and monitoring of negative effects that may occur because of the use of pharmaceutical products and other drugs. PV services cater to a wide range of drug related activities such as discovery of a drug to its commercialization. It also helps with the utilization of tools and software that reviews, classifies data on drugs and ... Read more
Boehringer Ingelheim is a German-based Pharmaceutical company. The company’s key interests are respiratory diseases, metabolism, and immunology and oncology diseases. The company partnered with AMPATH to scale up knowledge, skills, and training for healthcare providers in Kenya. The company launched the first veterinary vaccines produced in China. Boehringer Ingelheim Biopharmaceuticals China expands commercial manufacturing capacities
Boehringer Ingelheim is a German-based Pharmaceutical company. The company’s key interests are respiratory diseases, metabolism, and immunology and oncology diseases. The company partnered with AMPATH to scale up knowledge, skills, and training for healthcare providers in Kenya. The company launched the first veterinary vaccines produced in China. Boehringer Ingelheim Biopharmaceuticals China expands commercial manufacturing capacities
The Pharmacovigilance market is set to see an impressive CAGR (Compound Annual Growth Rate) between 2014 and 2020. This will bring to fore lucrative opportunities of growth and pull up market worth significantly. Factors of growth are multiple but foremost among them are strict government regulations, and robust pipeline of drugs. Moreover, the rising incidences of adverse drug reactions are a major ... Read more
According to MRFR analysis, Pharmacovigilance Market is expected to register a CAGR of 14.1% during the forecast period of 2019 to 2025 and accounts for USD 4321.86 Million 2018.
Pharmacovigilance supports safe and appropriate use of drugs by identifying risk factors for ... Read more
Pharmacovigilance is the science and practice of monitoring and assessing the safety and efficacy of pharmaceutical products after they have been approved for use in the market. It plays a vital role in identifying and managing adverse drug reactions (ADRs) and ensuring the overall safety of drugs. With advancements in biomedical research, pharmacogenomics has emerged as a promising area that intersects pharmacovigilance, offering new insights into individual responses to drugs based on ... Read more
The global Pharmacovigilance Market is estimated to be valued at USD 8.5 billion in 2022 and is expected to exhibit a CAGR of 8.5% over the forecast period 2023-2032, as highlighted in a new report published by Coherent Market Insights.
A) Market Overview:
The Pharmacovigilance market primarily focuses on drug safety. It involves the collection, monitoring, detection, and prevention of adverse effects associated with pharmaceutical products. Pharmacovigilance helps ... Read more
